McClelland, G A <br/><br/>
Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form.  [electronic resource] 

 -  Pharmaceutical research  Jul 1991 
 - 873-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0724-8741 
<br/><br/><label>Standard No.: </label>10.1023/a:1015899328105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cholesterol--blood<br/>Chromatography, High Pressure Liquid<br/>Delayed-Action Preparations<br/>Dogs<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors<br/>Lovastatin--administration & dosage<br/>Osmotic Pressure<br/>Simvastatin<br/>Solubility<br/>Tablets